PRESS RELEASE published on 04/16/2025 at 17:45, 7 months 18 days ago Le Groupe Keyrus entre en négociation exclusive avec le Groupe Astek afin de céder ses activités Life Sciences CRO Keyrus annonce la phase finale de négociation pour la cession de ses activités Life Science CRO au groupe Astek, dans le cadre de sa stratégie de recentrage. Décision stratégique pour renforcer sa position sur la donnée, l'IA et le digital Keyrus Recentrage Négociation Astek Life Science CRO
BRIEF published on 09/26/2024 at 17:50, 1 year 2 months ago Keyrus 2024 half-year results: a notable drop Financial Results Turnover Keyrus Mid-Market Key Accounts
BRIEF published on 09/26/2024 at 17:50, 1 year 2 months ago Résultats semestriels 2024 de Keyrus : une baisse notable Chiffre D'affaires Résultats Financiers Keyrus Grands Comptes Mid-Market
PRESS RELEASE published on 09/26/2024 at 17:45, 1 year 2 months ago Résultats semestriels 2024 Keyrus annonce chiffre d'affaires S1 2024 de 178,1M€, en baisse de 4,6%, résultats opérationnels et financiers du premier semestre 2024. Perspectives et focus sur croissance et innovation Chiffre D'affaires Résultats Financiers Croissance Innovation Keyrus
BRIEF published on 04/18/2024 at 17:50, 1 year 7 months ago Bilan Annuel 2023 de Keyrus Progiware : Progression Sous Tension Croissance Des Ventes Stratégie ESG Résultats Annuels 2023 Keyrus Progiware Investissements En Intelligence Artificielle
BRIEF published on 04/18/2024 at 17:50, 1 year 7 months ago Keyrus Progiware 2023 Annual Review: Progress Under Tension Sales Growth 2023 Annual Results ESG Strategy Keyrus Software Investments In Artificial Intelligence
PRESS RELEASE published on 04/18/2024 at 17:45, 1 year 7 months ago Résultats Annuels 2023 Keyrus annonce une croissance de 5,2% de son chiffre d'affaires en 2023 avec des résultats opérationnels en hausse. La stratégie future se concentre sur l'innovation et l'agilité Chiffre D'affaires Croissance Keyrus Résultats Opérationnels Stratégie Future
Published on 12/05/2025 at 02:35, 5 hours 32 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 7 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 2 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 7 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 6 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 36 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 16 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 41 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 51 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 52 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 7 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 7 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 22 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 22 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
